Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before-after cohort study using mixed effects regression.

dc.contributor.affiliationDepartment of Infectious Disease, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
dc.contributor.affiliationUniversity of California San Francisco, San Francisco, California, USA.
dc.contributor.affiliationSan Francisco General Hospital and Trauma Center, San Francisco, California, USA.
dc.contributor.affiliationZambia Ministry of Health, Lusaka, Zambia.
dc.contributor.affiliationDivision of Global HIV & Tuberculosis, Centers for Disease Control and Prevention, Lusaka, Zambia.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia, Lusaka, Zambia jmpry@ucdavis.edu.
dc.contributor.affiliationInstitute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
dc.contributor.affiliationDepartment of Public Health Environments and Society, London School of Hygiene & Tropical Medicine, London, UK.
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
dc.contributor.affiliationDepartment of Internal Medicine, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA.
dc.contributor.affiliationCIDRZ
dc.contributor.affiliationCentre for Infectious Disease Research in Zambia (CIDRZ)
dc.contributor.authorPry JM
dc.contributor.authorSikombe K
dc.contributor.authorMody A
dc.contributor.authorIyer S
dc.contributor.authorMutale J
dc.contributor.authorVlahakis N
dc.contributor.authorSavory T
dc.contributor.authorWa Mwanza M
dc.contributor.authorMweebo K
dc.contributor.authorMwila A
dc.contributor.authorMwale C
dc.contributor.authorMukumbwa-Mwenechanya M
dc.contributor.authorKerkhoff AD
dc.contributor.authorSikazwe I
dc.contributor.authorBolton Moore C
dc.contributor.authorMwamba D
dc.contributor.authorGeng EH
dc.contributor.authorHerce ME
dc.date.accessioned2025-05-23T11:40:51Z
dc.date.issued2022-Jan
dc.description.abstractINTRODUCTION: The Zambian Ministry of Health (MoH) issued COVID-19 mitigation guidance for HIV care immediately after the first COVID-19 case was confirmed in Zambia on 18 March 2020. The Centre for Infectious Disease Research in Zambia implemented MoH guidance by: 1) extending antiretroviral therapy (ART) refill duration to 6 multi-month dispensation (6MMD) and 2) task-shifting communication and mobilisation of those in HIV care to collect their next ART refill early. We assessed the impact of COVID-19 mitigation guidance on HIV care 3 months before and after guidance implementation. METHODS: We reviewed all ART pharmacy visit data in the national HIV medical record for PLHIV in care having ≥1 visit between 1 January-30 June 2020 at 59 HIV care facilities in Lusaka Province, Zambia. We undertook a before-after evaluation using mixed-effects Poisson regression to examine predictors and marginal probability of early clinic return (pharmacy visit >7 days before next appointment), proportion of late visit (>7 days late for next appointment) and probability of receiving a 6MMD ART refill. RESULTS: A total of 101 371 individuals (64% female, median age 39) with 130 486 pharmacy visits were included in the analysis. We observed a significant increase in the adjusted prevalence ratio (4.63; 95% CI 4.45 to 4.82) of early return before compared with after guidance implementation. Receipt of 6MMD increased from a weekly mean of 47.9% (95% CI 46.6% to 49.2%) before to 73.4% (95% CI 72.0% to 74.9%) after guidance implementation. The proportion of late visits (8-89 days late) was significantly higher before (18.8%, 95% CI17.2%to20.2%) compared with after (15.1%, 95% CI13.8%to16.4%) guidance implementation . CONCLUSIONS: Timely issuance and implementation of COVID-19 mitigation guidance involving task-shifted patient communication and mobilisation alongside 6MMD significantly increased early return to ART clinic, potentially reducing interruptions in HIV care during a global public health emergency.
dc.identifier.doi10.1136/bmjgh-2021-007312
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10321
dc.sourceBMJ global health
dc.titleMitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before-after cohort study using mixed effects regression.

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
article.pdf
Size:
1.17 MB
Format:
Adobe Portable Document Format

Collections